These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20542034)

  • 1. Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers.
    Henson JD; Reddel RR
    FEBS Lett; 2010 Sep; 584(17):3800-11. PubMed ID: 20542034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomeres and telomerase in sarcomas.
    Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
    Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere length maintenance--an ALTernative mechanism.
    Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE
    Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
    Nittis T; Guittat L; Stewart SA
    Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
    Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
    Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
    Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
    J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of alternative lengthening of telomeres mechanisms in carcinogenesis and prospects for using an anti-telomerase drugs in malignant tumors treatment].
    Grach AA
    Tsitologiia; 2011; 53(10):759-71. PubMed ID: 22232932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
    Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
    Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative lengthening of telomeres does exist in various canine sarcomas.
    Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
    Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative lengthening of telomeres in human cells.
    Reddel RR; Bryan TM; Colgin LM; Perrem KT; Yeager TR
    Radiat Res; 2001 Jan; 155(1 Pt 2):194-200. PubMed ID: 11121234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.
    Londoño-Vallejo JA; Der-Sarkissian H; Cazes L; Bacchetti S; Reddel RR
    Cancer Res; 2004 Apr; 64(7):2324-7. PubMed ID: 15059879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
    Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
    Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative lengthening of telomeres is induced by telomerase inhibitors in Barrett's esophageal cells.
    Qin X; Qi B; Zhao B
    Oncol Rep; 2013 Apr; 29(4):1399-404. PubMed ID: 23338150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative lengthening of telomeres, telomerase, and cancer.
    Reddel RR
    Cancer Lett; 2003 May; 194(2):155-62. PubMed ID: 12757973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
    Min J; Wright WE; Shay JW
    Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ALT--alternative lengthening of telomere].
    Wu XM; Tang WR; Luo Y
    Yi Chuan; 2009 Dec; 31(12):1185-91. PubMed ID: 20042385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
    Gocha ARS; Harris J; Groden J
    Mutat Res; 2013; 743-744():142-150. PubMed ID: 23219603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.